Skip to main content
. 2018 Feb 5;183(5-6):e223–e231. doi: 10.1093/milmed/usx071

Table IV.

Mean Scores on Baseline Measures and of Change Between Baseline and Post-test Comparing Participants by Adjuvant Therapy and Baseline PCL-M Score (N = 18)

Measure Adjuvant Therapy p-Value Baseline PCL-M Score p-Value
No (n = 12) Yes (n = 6) Score <50 (n = 11) Score 50+ (n = 7)
PCL-M
 Baseline 41.0 (12.1) 61.0 (10.9) 0.004 36.9 (5.7) 64.6 (5.9) <0.001
 Change 14.6 (7.8) 23.7 (9.1) 0.042 12.2 (5.1) 26.1 (7.2) <0.001
PSQI
 Baseline 11.8 (5.1) 15.5 (3.0) 0.120 10.5 (4.4) 17.0 (1.5) 0.002
 Change 3.1 (3.1) 3.8 (3.2) 0.637 3.2 (3.3) 3.6 (2.8) 0.800
PHQ-8
 Baseline 9.3 (6.1) 17.0 (3.8) 0.013 8.1 (4.8) 17.9 (3.5) <0.001
 Change 14.4 (9.1) 27.2 (6.9) 0.008 12.2 (6.6) 28.9 (5.4) <0.001
BAI
 Baseline 14.0 (10.4) 33.0 (5.6) 0.001 12.2 (8.5) 33.1 (5.6) <0.001
 Change 5.8 (4.8) 15.7 (5.4) 0.001 6.5 (5.8) 13.1 (6.7) 0.041
MAAS
 Baseline 56.6 (17.1) 30.7 (8.2) 0.003 58.3 (17.0) 31.7 (7.6) 0.001
 Change −9.2 (13.5) −17.8 (6.4) 0.159 −7.8 (13.4) −18.7 (5.8) 0.061

Numbers in italics are the p-values.